Antimicrobial Agents and Chemotherapy
- Transmission-blocking activities of artesunate, chloroquine, and methylene blue on Plasmodium vivax gametocytes
- First-in-human, randomized, double-blind, placebo-controlled, single and multiple ascending doses clinical study to assess the safety, tolerability, and pharmacokinetics of cipargamin administered intravenously in healthy adults
- Pbp4 provides transpeptidase activity to the FtsW-PbpB peptidoglycan synthase to drive cephalosporin resistance in Enterococcus faecalis
- Elucidating the potential of isorhapontigenin in targeting the MgrA regulatory network: a paradigm shift for attenuating MRSA virulence
- Therapeutic efficacy of pyronaridine-artesunate (Pyramax) in treating Plasmodium vivax malaria in the central highlands of Vietnam
- Enhanced fatty acid biosynthesis by Sigma28 in stringent responses contributes to multidrug resistance and biofilm formation in Helicobacter pylori
- EfpA is required for regrowth of Mycobacterium tuberculosis following isoniazid exposure
- A picomolar inhibitor of the Plasmodium falciparum IPP pathway
- Case Commentary: Extending our therapeutic range against multidrug-resistant Candida
- Oral flucytosine dosing in peritoneal dialysis
- Population pharmacokinetics of rifabutin among HIV/TB co-infected children on lopinavir/ritonavir-based antiretroviral therapy
- Rifabutin central nervous system concentrations in a rabbit model of tuberculous meningitis
- Phenazine-1 carboxylic acid of Pseudomonas aeruginosa induces the expression of Staphylococcus aureus Tet38 MDR efflux pump and mediates resistance to phenazines and antibiotics
- Indigenous emergence and spread of kelch13 C469Y artemisinin-resistant Plasmodium falciparum in Uganda
- Identification of novel bromodomain inhibitors of Trypanosoma cruzi bromodomain factor 2 (TcBDF2) using a fluorescence polarization-based high-throughput assay
- Effect of L-arginine on cystic fibrosis Pseudomonas aeruginosa biofilms
- The interaction of the azetidine thiazole side chain with the active site loop (ASL) 3 drives the evolution of IMP metallo-β-lactamase against tebipenem
- Cimicifugin, a broad-spectrum inhibitor of Theileria annulata and Plasmodium falciparum CDK7
- Remdesivir treatment does not reduce viral titers in patients with COVID-19by Isa FaghihiVictoria C. Yan1University of Texas Southwestern Medical Center, Dallas, Texas, USAMiguel Angel Martinez on July 18, 2024 at 7:00 am
- H2 inhalation therapy in patients with moderate COVID-19 (H2COVID): a prospective ascending-dose phase I clinical trial